INHIBITEUR D'ACTIVATION DES LYMPHOCYTES T, COMPOSITION PHARMACEUTIQUE CONTENANT CELUI-CI, ET PROCÉDÉ DE CRIBLAGE POUR UNE SUBSTANCE INHIBANT L'ACTIVATION DES LYMPHOCYTES T

• 收藏
• 分享

专利权人:

MITSUBISHI TANABE PHARMA CORPORATION

发明人:

YAMASHITA, TOSHIHIDE,KUBO, TAKEKAZU

申请号：

EP10835979

公开号：

EP2510948A4

申请日:

2010.12.08

申请国别(地区):

EP

年份:

2013

代理人:

摘要：

Provided is a T cell activation inhibitor containing an RGM inhibiting substance such as an anti-RGM neutralizing antibody and the like as an active ingredient. The T cell activation inhibitor is useful as a pharmaceutical composition for the prophylaxis or treatment of autoimmune diseases such as multiple sclerosis and the like, and other diseases caused by T cell activation. In addition, a T cell activation inhibiting substance can be screened for by contacting a test substance with RGM and selecting a test substance that lowers the activity level of RGM.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/